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The aim of this study was to investigate the antidepressant-like effect of fractions from Rosmarinus ofﬁ-
cinalis L.: ethyl acetate 1 and 2 (AcOEt1 and 2), hexane (HEX), ethanolic (ET), and essential oil-free (EOF)
fractions, as well as essential oil, the isolated compounds carnosol and betulinic acid in the tail suspen-
sion test, a predictive test of antidepressant activity. Swiss mice were acutely administered by oral route
(p.o.) with fractions, essential oil or isolated compounds, 60 min before the tail suspension test or open-
ﬁeld test. All of them produced a signiﬁcant antidepressant-like effect: AcOEt1, ET, EOF fractions and
essential oil (0.1–100 mg/kg, p.o); HEX (0.1–10 mg/kg, p.o) and AcOEt2 fraction (0.1–1 mg/kg, p.o), car-
nosol (0.01–0.1 mg/kg, p.o.) isolated from the HEX fraction and betulinic acid (10 mg/kg, p.o.), isolated
from the AcOEt1 and AcOEt2 fractions. No psychostimulant effect was shown in the open-ﬁeld test, indi-
cating that the effects in the tail suspension test are speciﬁc. This study suggests that carnosol and bet-
ulinic acid could be responsible for the anti-immobility effect of extracts from R. ofﬁcinalis.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Depression is one of the major mental disorders associated with
considerable morbidity and mortality, unfortunately with a consis-
tently high prevalence worldwide. The lifetime prevalence of
depression has been estimated to be as high as 21% of the general
population in some developed countries (Wong & Licinio, 2001).
Despite the introduction of various classes of antidepressants,
including tricyclics, selective reversible inhibitors of monoamine
oxidase, selective serotonin reuptake inhibitors and speciﬁc
serotonin–noradrenaline reuptake inhibitors, the treatment of
depression is not entirely satisfactory, since these conventional
treatment modalities are hindered by adverse effects and generally
produce only a partial remission (Richelson, 1994; Taylor & Stein,
2005).
Herbal therapies may be effective alternatives in the treatment
of depression. Moreover, pharmacotherapy with medicinal plants
can offer advantages in terms of safety and tolerability, possiblyt1, ethyl acetate 1; AcOEt 2,
essential oil-free; TST, tail
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evier OA license.also improving patient compliance (Richelson, 1994). The search
of extracts and isolated compounds of plants has progressed signif-
icantly (Zhang, 2004) and this fact could be due, in part, to the need
to identify new therapeutic alternatives for treatment of psychiat-
ric illnesses, including depression.
Rosemary, Rosmarinus ofﬁcinalis L. (Labiatae) is an evergreen
perennial shrub, native to Europe, that has been cultivated in many
parts of the world, including Brazil (Balmé, 1978; Duke, 2000). The
leaves of this plant are commonly used as a condiment to season
food, and as a source of antioxidant compounds for food conserva-
tion (Zeng et al., 2001). The essential oil of R. ofﬁcinalis has been re-
ported to exhibit antiproliferative, antioxidant and antibacterial
activities (Hussain et al., 2010).
Furthermore, the ethnopharmacological uses of tea, infusions,
alcoholic extract and oil of R. ofﬁcinalis include the treatment of
several disorders, such as inﬂammatory diseases, physical and
mental fatigue, and treatment of nervous agitation and depression,
among other applications (Balmé, 1978; Duke, 2000; Heinrich, Ku-
fer, Leonti, & Pardo-de-Santayana, 2006).
Pharmacological studies, carried out with the extract and essen-
tial oil from R. ofﬁcinalis, show that this plant exerts several biolog-
ical effects, such as: antioxidant (Bakirel, Bakirel, Keles, Ülgen, &
Yardibi, 2008), antidiabetic (Bakirel et al., 2008), antinociceptive
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atti, & Fröde, 2011; Takaki et al., 2008), and antimicrobial activities
(Mangena & Muyima, 1999), among others. We have recently
shown that the hydroalcoholic crude extract of R. ofﬁcinalis (orally
administered to mice) produces an antidepressant-like effect in the
forced swimming test (FST) and tail suspension test (TST), predic-
tive tests of antidepressant activity, by a mechanism dependent on
the interaction with the monoaminergic systems (Machado et al.,
2009).
Phytochemical studies have reported the biologically active
compounds in this plant, such as terpenoids, e.g. carnosol, carnosic
acid, rosmanol, oleanolic and ursolic acids, ﬂavonoids including
diosmin, luteolin, apigenin and quercetin and phenols, such as caf-
feic and rosmarinic acids. Furthermore, these compounds have
shown antioxidant, anti-inﬂammatory and antinociceptive proper-
ties in pre-clinical studies (Altinier et al., 2007; Barnes, Anderson, &
Phillipson, 2001; Benincá et al., 2011; Frankel, Huang, Aeschbach,
& Prior, 1996).
Considering the recent evidence of the antidepressant-like ef-
fect of R. ofﬁcinalis by our group from in vivo experiments, the eth-
nopharmacological use of this plant for treatment of depression
and that the herbal medicines include a range of pharmacologically
active compounds, this study aimed at isolating and identifying the
major components of R. ofﬁcinalis, that may be contributing, at
least in part, to its antidepressant potential.2. Materials and methods
2.1. Plant material and production of crude extract
Stems and leaves of R. ofﬁcinalis (Labiatae) were collected in
Santo Amaro da Imperatriz Santa Catarina, and identiﬁed by Dr.
Daniel Falkenberg, from the Department of Botany, Federal Univer-
sity of Santa Catarina. A voucher specimen (Excicata number
34918) was deposited in the Herbarium of the Department of Bot-
any, Federal University of Santa Catarina, Santa Catarina, Brazil.
The preparation of crude extract was carried out as described pre-
viously (Machado et al., 2009). Brieﬂy, dried aerial parts of R. ofﬁ-
cinalis (600 g) were subjected to extraction by maceration as
follows: the plant material was placed in a closed vessel and etha-
nol (96%) was added and allowed to stand for ﬁfteen days at room
temperature (25 ± 2 C), and shaken occasionally. Thereafter, the
extract was ﬁltered and then concentrated under reduced pressure
(at approximately 60). The maceration was repeated three times.
After removing the solvent by lyophilisation, this procedure gave
61 g of a green solid and dry hydroalcoholic crude extract (10.2%
w/w yield).2.2. Production of fractions and isolation of compounds
The crude extract (61 g) was chromatographed on a silica gel 60
(Vetec – 0.063–0.2 mesh) column and eluted, ﬁrst with hexane
(600 ml), then followed by ethyl acetate (600 ml) and ethanol
(600 ml), to give the hexane (HEX: 13.3 g, 21.8%), ethyl acetate
(AcOEt1: 8.83 g, 14.5% and AcOEt2: 15.48 g, 25.3%) and ethanolic
(ET: 13 g, 21%) fractions. Part of the HEX fraction (9.37 g) was sub-
mitted to a chromatographic column (4 cm i.d.  45 cm long) with
silica gel 60 (Vetec – 0.063–0.2 mesh), using hexane–ethyl acetate
solutions with increasing polarity as eluents, to afford 13 fractions.
Fractions 8–9, which were eluted with hexane–ethyl acetate
(75:25, v/v), were dried at room temperature (25 C) and puriﬁed
by crystallisation in acetone (500 ll, 99%, Vetec) to give the pheno-
lic diterpene carnosol (CA) (Compound 1) (76 mg, 0.8%). This iso-
lated compound presents as colourless crystals, with a melting
point (m.p.) of 215–219 C (Fig. 1). Part of the AcOEt fraction(8.83 g) was also submitted to a silica gel column, using hexane–
ethyl acetate solutions in increasing order of polarity as eluent,
to give 33 fractions. Fractions 7–9 were pooled and eluted with
hexane–ethyl acetate (75:25, v/v) and puriﬁed by crystallisation
in ethanol, yielding the triterpene betulinic acid (BA) (Compound
2) (43 mg, 0.48%). BA presented as a white powder, with an m.p.
of 296–298 C (Fig. 1). The structures of the known compounds
were identiﬁed by spectroscopic data (1 H NMR, 13 C NMR (Varian
AS-400 – Palo Alto, CA, USA), and IR – Perkin–Elmer FTIR 16 PC,
Beaconsﬁeld, England). The results were compared with spectral
data obtained from the literature (Mahato & Kundu, 1994; Pukals-
kas, Van Beek, & Waard, 2005), as well as co-thin-layer chromatog-
raphy with commercial standard compounds (Sigma–Aldrich,
Steinheim, Germany).
2.3. HPLC proﬁle of R. ofﬁcinalis fractions
The liquid chromatography (HPLC) proﬁle was obtained using
Varian ProStar 310 equipment with a UV/vis detector (monitoring
210 nm) (Walnut Creek, CA, USA), a manual injector, and the Star-
Finder version 5.5 software. The HPLC apparatus was equipped
with a ChromSpher 5 C18 column (4.6 and 250 mm i.d.) (Walnut
Creek, CA, USA). In the mobile phase, the following solvents were
used: methanol (A), acetonitrile (B) and water (C) with a ﬂow rate
of 1.0 ml/min. The following elution proﬁle was used: 0–7.5 min
60:0:40 (A:B:C) (isocratic); 7.5–20 min 0:100:0 (linear); 20–
25 min 0:100:0 (isocratic). An equilibration period of 10 min was
also included between runs. The carnosol, used as standard for
quantiﬁcation, was obtained according to Benincá et al. (2011).
The triterpenes betulinic acid, oleanolic acid, ursolic acid and ros-
marinic acid (Sigma–Aldrich, Steinheim, Germany) were used as
standards. To conﬁrm the peaks in the HPLC analysis, comparison
of its retention times and co-injection of standards were used.
The spectroscopic data of carnosol and betulinic acid, used in this
experiment, were previously reported by Benincá et al. (2011). Cal-
ibration curves were prepared with standard solutions of investi-
gated compounds in the concentration range from 0.01 to
1.5 mg ml1. Five standard solutions were injected in triplicate.
The calibration curves were constructed by linear regression of
the peak-area ratios (y) of each analyte, versus concentrations
(x). The r2 values were in the range from 0.990 to 0.999, which con-
ﬁrmed the linearity of the method.
2.4. Distilation of essential oil and preparation of essential oil-free
fraction
Fresh aerial parts (200 g) were ground prior to the operation
and then ground rosemary was submitted to water distilation for
4 h using a Clevenger apparatus. The distiled essential oil was dried
over anhydrous sodium sulphate, ﬁltered and stored at 4 C. After
removing the essential oil, the leaves were re-extracted with alco-
hol (96%) to obtain the essential oil-free fraction (13.2 g, 6.6%,
yield).
2.5. Gas chromatographic analysis
The GC-FID technique in this study was used to quantify the
compounds present in the essential oil and it was performed on
a gas chromatograph (GC) -Shimadzu 14 B with a ﬂame ionisation
detector (GC-FID), column OV-5 (30 m  0.25 mm i.d.  0.25 lm
ﬁlm), N2 as ﬂow gas with constant pressure of 80 kPa. The split ra-
tio was 1/150 and injection volume was 0.3 ll of the oil. Injector
and detector were held at 250 and 300 C, respectively. The follow-
ing programmewas: 50 C for 3 min, rate of 5 C min1 until 270 C
and held for 8 min. The GC–MS was used to identify the com-
pounds and it was performed on a gas cromatograph coupled with
Essential oil
(3.7ml)
Fresh plant material
Filtration on a column of silica
Dried and ground 
plant material 
(600g)
Hydroalcoholic 
crude extract 
(61g)
Maceration in 96% ethanol
Hexane (HEX) 
Fraction
(13.38g)
Ethanolic (ET)
Fraction 
 (13.23g)
Ethyl acetate (AcOEt) 
Fraction 
(1 and 2), (27.91g) 
Carnosol Betulinic acid
Essential oil-free (EOF) 
Fraction
 (13.2g)
Distilation, 4h
Maceration in 96% ethanol
Rosmarinus officinalis
Fig. 1. Scheme of fractionation and isolation of the compounds and production of the essential oil of R. ofﬁcinalis.
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ning (1 scan s1) was performed in the range of 39–400m/z and
using electron impact ionisation at 70 eV. The column used was
CPSil 8CB (30 m  0.25 mm i.d., 0.25 lm ﬁlm). Analyses were car-
ried out using helium as carrier gas at a ﬂow rate of 1.0 ml min1 in
a split ratio of 1:20 and the following programme rate was: 50 C
held for 1 min, rate of 3 C min1 until 240 C; injector: 250 C.
The compounds were identiﬁed using the: (1) arithmetic indices
(AI), (2) GC–MS retention indices (authentic chemicals), and mass
spectra (authentic chemicals and NIST98 spectral library collec-
tion). The Sigma retention index standard (Sigma Aldrich, USA),
used in this study, consisted of a mixture of aliphatic hydrocar-
bons, ranging from C10 through C30, dissolved in hexane. It is de-
signed to be used to obtain the arithmetic indices type gas
chromatographic retention indices, which are useful for prelimin-
ary identiﬁcation of unknown compounds. In this study the arith-
metic retention index value is calculated for a peak by comparing
its retention characteristics to those of the two closest eluting ali-
phatic hydrocarbons from the retention index standard, analysed
under identical conditions. Presumptive identiﬁcations can often
be made by comparing the arithmetic retention index value to a
value previously published in literature references (Adams, 2007).2.6. Animals
Male Swiss mice (60 to 70 days old weighing 45–50 g) were
maintained at constant room temperature (21 ± 1 C) with free ac-
cess to water and food, under a 12:12 h light:dark cycle (lights on
at 07:00 h). Mice were allowed to acclimatise to the holding roomfor 24 h before the behavioural procedure. Animals were randomly
distributed into speciﬁed experimental groups. All experiments
were carried out between 9:00 and 16:00 h, with each animal used
only once (N = 6–9 animals per group). The procedures in this
study were performed in accordance with the National Institute
of Health Guide for the Care and Use of Laboratory Animals and ap-
proved by the Ethics Committee of the Institution. All efforts were
made to minimise animal suffering and to reduce the number of
animals used in the experiments.2.7. Drugs and treatment
The fractions, hexane (HEX), ethyl acetate (AcOEt), ethanolic
(ET), and essential oil-free fraction (EOF) of R. ofﬁcinalis (0.1–
100 mg/kg) were administered acutely by oral route (p.o.) 60 min
before the TST or open-ﬁeld test. To address some of the com-
pounds isolated from the extract of R. ofﬁcinalis as possible active
principles responsible for the antidepressant-like effect or that
cause antidepressant-like action in the TST, animals were treated
with carnosol (0.01–10 mg/kg, p.o.) and betulinic acid (0.1–
10 mg/kg, p.o.), which were dissolved in distiled water with 10%
Tween 80 and administered acutely by oral route (p.o.), 60 min be-
fore the TST or open-ﬁeld test. In another set of experiments, the
essential oil was dissolved in mineral oil and administered acutely
by oral route (p.o.) 60 min before the TST or open-ﬁeld test. The
dissolution of fractions, isolated compounds and essential oil was
done immediately before their administration by gavage, which
was performed in a constant volume of 10 ml/kg body weight.
Drugs were dissolved in distiled water with 10% Tween 80, except
Table 1
Content of phenolic and terpene compounds in fractions of R. ofﬁcinalis (mg/g of fraction) and relative standard deviation (RSD). Each content value is the mean of three
replications.
Compound HEX RSD, % AcOEt 1 RSD, % AcOEt 2 RSD, % ETOH RSD, % EOF RSD, %
Rosmarinic acid 17.0 0.9 n.d. – 7.9 0.43 4.9 1.2 47.4 6.5
Carnosol 58.3 2.3 371 5.4 82.7 3.3 n.d. – 128 4.6
Betulinic acid n.d. – n.d. – 102 4.1 30.6 4.8 21.4 1.5
Oleanolic acid n.d. – n.d. – 79.3 1.8 9.5 2.4 12.1 0.6
Ursolic acid n.d. – n.d. – 483 6.6 185 5.5 49.5 3.2
n.d. = not detected.
Table 2
Mean percentage composition of essential oil of R. ofﬁcinalis.
Compound RT % REL AIt AIc
a-Pinene 11.42 4.62 932 931
Camphene 12.13 1.37 946 948
b-Pinene 13.61 1.07 974 972
b-Mircene 14.57 0.54 988 986
p-Cymene 16.23 0.76 1020 1018
1,8 Cineol 16.61 45.1 1026 1024
b-Linalool 20.34 1.26 1095 1093
Camphor 22.49 21.8 1141 1139
Borneol 23.65 4.77 1165 1164
4-Terpineol 24.25 1.12 1174 1171
a-Terpineol 24.95 4.57 1186 1185
RT = retention time (min); %REL = relative percentage; AIt = Theoretical arithmetical
index; AIc = Calculated arithmetic index.
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ethanol. The control groups received appropriate vehicle (distiled
water or mineral oil). Fluoxetine (10 mg/kg, p.o.) from Sigma
Chemical Company (St. Louis, MO, U.S.A.), a conventional antide-
pressant, was used as a positive control.
2.8. Behavioural tests
2.8.1. Tail suspension test (TST)
The total duration of immobility induced by tail suspension was
measured according to the method described by Steru, Chermat,
Thierry, and Simon (1985). Brieﬂy, mice (both acoustically and
visually isolated) were suspended 50 cm above the ﬂoor by adhe-
sive tape placed approximately 1 cm from the tip of the tail. Immo-
bility time was registered during a 6 min period (Machado et al.,
2009).
2.8.2. Open-ﬁeld test
To assess the possible effects of the fractions, isolated com-
pounds and essential oil of R. ofﬁcinalis on locomotor activity mice
were evaluated in the open-ﬁeld paradigm, as previously described
(Machado et al., 2009). Mice were individually placed in a wooden
box (40  60  50 cm) with the ﬂoor divided into 12 squares.
Number of crossings (number of squares crossed by the animal
with the four paws) was used to evaluate locomotor activity
(Machado et al., 2009). These parameters were registered in a
6 min period.
2.9. Statistical analysis
Comparisons between experimental and control groups were
performed by one-way-ANOVA, (dose–response curves), followed
by Tukey’s HSD post hoc test when appropriate. A value of
P < 0.05 was considered to be signiﬁcant.
3. Results
3.1. General
Several fractions, essential oil and isolated compounds were
submitted to a biological and phytochemical investigation to study
their antidepressant-like activity following a bioassay-oriented
fractionation and compound isolation procedure.
3.2. Phytochemical analysis and high-performance liquid
chromatographic proﬁle (HPLC)
The correlation coefﬁcients (r2) and their regression equations
of calibration curves for silylated compounds were: rosmarinic
acid (0.9900; y = 2E + 07x  12203), carnosol (0.9980; y = 2E +
07 + 33239); betulinic acid (0.9990; y = 2E + 06 + 20006), oleanolic
acid (0.9980; y = 3E + 06 + 19108). These compounds and ursolic
are shown in Table 1. The compounds quantiﬁed were: carnosol,
ursolic acid, oleanolic acid, betulinic acid and rosmarinic acid in(mg/g of fraction) and relative standard deviation (RSD). In this
context, as observed in Table 1, carnosol is as major compound
in the AcOEt 1, EOF and HEX fractions. However, ursolic acid is
more pronounced in the AcOEt 2 and ETOH fractions. Although
present at a lower concentration, the triterpene, betulinic acid,
was found mainly in the AcOEt 2, ETOH and EOF fractions. The phe-
nolic acid, rosmarinic acid, was found mainly in the EOF fraction
and oleanolic acid in the AcOEt 2 fraction.3.3. Essential oil analysis
Eleven compounds, representing 87.0% of the total oil, were
identiﬁed (Table 2). The main volatiles were 1,8-cineole, camphor,
a-pinene, borneol and a-terpineole.3.4. Behavioural analysis
3.4.1. Effect of acute treatment with the fractions of R. ofﬁcinalis on the
immobility time in the TST and locomotor activity in the open-ﬁeld test
The effects of p.o. administration of all the fractions of R. ofﬁci-
nalis on the immobility time in the TST are shown in Table 3. The
AcOEt 1 fraction of R. ofﬁcinalis, administered at 0.1, 1, 10,
100 mg/kg, decreased the immobility time in the TST as compared
to the control group: [F(4,42) = 6.29, P < 0.01], without causing
changes in the locomotor activity: [F(4,26) = 0.26, P = 0.90].
The AcOEt 2 fraction of R. ofﬁcinalis, given at the doses of 0.1 and
1 mg/kg, p.o. decreased the immobility time in the TST, as com-
pared to the control group: [F(4,35) = 23.19, P < 0.01], but de-
creased the number of crossings in the open-ﬁeld test only at the
dose of 0.1 mg/kg: [F(4,32) = 2.81, P < 0.05].
The HEX fraction of R. ofﬁcinalis reduced the immobility time in
the TST (0.1, 1 and 10 mg/kg, p.o.) as compared to the control
group: [F(4,40) = 22.99, P < 0.01]. At these doses, the HEX fraction
did not affect locomotor activity, but reduced the number of cross-
ings in the open-ﬁeld test at the dose of 100 mg/kg, p.o., when
compared to the control group: [F(4,32) = 5.12, P < 0.01].
Table 3
Effect of the acute treatment of mice with fractions, essential oil and isolated
compounds of R. ofﬁcinalis on the immobility time in the tail suspension test and on
the number of crossings in the open-ﬁeld test.
Compound Dose (mg/kg, p.o.) Immobility time (s) Crossings
Vehicle – 227.3 ± 7.3 80.0 ± 11.9
AcOEt1 0.1 165.4 ± 7.9** 90.6 ± 9.4
AcOEt1 1 166.0 ± 12.1** 81.0 ± 9.0
AcOEt1 10 179.8 ± 8.7* 82.8 ± 13.9
AcOEt1 100 184.7 ± 14.3* 74.1 ± 12.2
Vehicle – 194.2 ± 4.6 83.6 ± 10.0
AcOEt2 0.1 141.1 ± 8.8** 33.8 ± 12.9*
AcOEt2 1 109.5 ± 10.5** 53.8 ± 16.6
AcOEt2 10 196.0 ± 7.2 80.8 ± 10.8
AcOEt2 100 181.0 ± 8.1 72.0 ± 10.0
Vehicle – 218.1 ± 4.2 82.0 ± 11.9
HEX 0.1 153.1 ± 7.9** 111.1 ± 13.1
HEX 1 118.8 ± 15.7** 71.1 ± 14.7
HEX 10 128.6 ± 7.0** 79.7 ± 14.1
HEX 100 186.2 ± 9.4 27.8 ± 6.9*
Vehicle – 203.5 ± 4.8 100.4 ± 10.3
ETOH 0.1 153.6 ± 17.5** 105.0 ± 7.2
ETOH 1 165.1 ± 3.4* 71.2 ± 20.1
ETOH 10 162.6 ± 10.2* 77.4 ± 14.7
ETOH 100 164.1 ± 7.3* 105.1 ± 9.3
Vehicle – 200.8 ± 5.5 39.2 ± 16.7
EOF 0.1 134.3 ± 6.1** 22.7 ± 7.9
EOF 1 131.7 ± 13.6** 30.8 ± 9.9
EOF 10 140.5 ± 15.4** 41.5 ± 13.9
EOF 100 131.0 ± 14.3** 45.1 ± 7.4
Vehicle – 236.1 ± 6.9 60.1 ± 18.3
EO 0.1 193.1 ± 8.6* 82.1 ± 8.9
EO 1 197.2 ± 11.6* 92.0 ± 8.3
EO 10 173.7 ± 10.8** 69.8 ± 17.4
EO 100 149.8 ± 7.2** 67.3 ± 5.2
Vehicle – 197.1 ± 2.7 53.9 ± 9.7
Carnosol 0.01 168.8 ± 7.7* 22.7 ± 6.1
Carnosol 0.1 165.7 ± 6.5** 25.0 ± 8.5
Carnosol 1 177.1 ± 8.0 32.8 ± 12.5
Carnosol 10 179.1 ± 5.9 11.6 ± 8.4*
Vehicle – 168.7 ± 5.4 51.0 ± 17.2
Betulinic acid 0.1 131.5 ± 15.4 52.1 ± 12.7
Betulinic acid 1 137.0 ± 13.7 34.0 ± 9.9
Betulinic acid 10 118.7 ± 11.8* 38.4 ± 9.7
Vehicle – 185.7 ± 6.5 43.5 ± 10.8
Fluoxetine 10 131.6 ± 7.6** 47.7 ± 13.7
The fractions and the isolated compounds were acutely administered by p.o. route
at the dose range indicated in the Table. The antidepressant ﬂuoxetine was used as
a positive control. Each column represents the mean ± S.E. of 6–9 animals.
* P < 0.05.
** P < 0.01 as compared with the vehicle-treated control group by Tukey’s HSD post
hoc test.
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oral route at 0.1, 1, 10 and 100 mg/kg, decreased the immobility
time in the TST as compared to the control group: [F(4,39) = 4.78,
P < 0.01], without causing changes in the locomotor activity of
mice: [F(4,30) = 1.51, P = 0.22].
3.4.2. Effect of acute treatment with essential oil and essential oil-free
fraction (EOF) of R. ofﬁcinalis on the immobility time in the TST and
locomotor activity in the open-ﬁeld test
Table 3 shows that the acute administration of essential oil and
of EOF fraction by oral route at 0.1, 1, 10 and 100 mg/kg decreased
the immobility time in the TST, as compared to the control group.
The one-way ANOVA revealed a signiﬁcant effect of essential oil
[F(4,35) = 12.52, P < 0.01] and EOF fraction [F(4,39) = 6.93,
P < 0.01] in the TST. Additionally, either essential oil or EOF fraction
caused no alteration in the locomotion of mice in the open-ﬁeld
test. The one way ANOVA did not show a signiﬁcant effect of thetreatment with essential oil [F(4,25) = 0.98, P = 0.43] or EOF frac-
tion [F(4,35) = 0.58, P = 0.67] in locomotor activity.3.4.3. Effect of acute treatment with isolated compounds of R.
ofﬁcinalis on the immobility time in the TST and locomotor activity in
the open-ﬁeld test
The effects of p.o. administration of carnosol, a compound iso-
lated from R. ofﬁcinalis, on the immobility time in the TST are
shown in Table 3. Carnosol, administered at the doses of 0.01
and 0.1 mg/kg, reduced the immobility time, as compared to the
control group [F(4,36) = 4.59, P < 0.01], but only reduced the loco-
motor activity in the open-ﬁeld when it was administered at
10 mg/kg, p.o.: [F(4,38) = 3.09, P < 0.05].
The results show that betulinic acid, another compound isolated
from R. ofﬁcinalis, administered by oral route at 10 mg/kg, de-
creased the immobility time in the TST as compared to the control
group [F(3,28) = 3.03, P < 0.05], but did not cause any signiﬁcant
change in the locomotion of mice as compared to the control group
at any doses tested (0.1–10 mg/kg) [F(3,31) = 0.52, P = 0.66].
We also showed that the antidepressant ﬂuoxetine (10 mg/kg,
p.o.), used here as a positive control, produced a signiﬁcant reduc-
tion in the immobility time in the TST [F(1,15) = 29.25, P < 0.01],
but did not affect locomotion in the open-ﬁeld-test: [F(1,12) =
0.05, P = 0.81].4. Discussion
The predictive validity of animal models of depression is deter-
mined solely by their response to antidepressant drugs (Cryan,
Mombereau, & Vassout, 2005). The TST is a behavioural model, pre-
dictive of antidepressant activity, that is sensitive to the acute
administration of antidepressants from different pharmacological
classes, extracts and isolated compounds of plants. In this test, ani-
mals are placed in an inescapable situation and the antidepressant-
like activity is expressed by the decreased immobility time as com-
pared with control groups (Capra et al., 2010; Cryan et al., 2005;
Machado et al., 2009; Steru et al., 1985). This behavioural test is
characterised exclusively by the behavioural effects of drugs used
clinically, but does not mimic the symptoms of disease (Cryan,
Markou, & Lucki, 2002; Cryan et al., 2005). Taking into account that
drugs that enhance locomotor activity may produce false positive
results in the TST, it is important to conduct experiments to assess
the effect of the compounds tested in the open-ﬁeld, in order to rule
out any interference of locomotion in the interpretation of results.
The present study showed that all fractions derived from the
crude extract of R. ofﬁcinalis produced an antidepressant-like effect
in the TST. Also, carnosol and betulinic acid, which are the main
compounds isolated from this plant, were able to cause a similar
effect, suggesting that they could, at least in part, be responsible
for the antidepressant activity of this plant. Interestingly, the
essential oil also demonstrated an anti-immobility effect in this
predictive test in mice. Notably, the effect of the extract of R. ofﬁ-
cinalis in the TST was similar to the effect produced by the oral
administration of ﬂuoxetine, used as a positive control. These re-
sults are consistent with the ethnopharmacological use of this
plant for the treatment of depression (Balmé, 1978; Duke, 2000;
Heinrich et al., 2006), reinforcing the previous evidence from our
group, which demonstrates the potential antidepressant effect of
the hydroalcoholic crude extract in this same experimental proto-
col (Machado et al., 2009). Moreover, the antidepressant-like activ-
ity of fractions (isolated compounds and essential oil of R.
ofﬁcinalis) cannot be attributable to any psychostimulant effect (in-
creased locomotion when assessed in the open-ﬁeld test).
In our study, the fractions (AcOEt 1, ET and EOF fractions) iso-
lated from R. ofﬁcinalis L. showed similar antidepressant-like effect
1004 D.G. Machado et al. / Food Chemistry 136 (2013) 999–1005in the dose range of 0.1–100 mg/kg, p.o. However, the AcOEt 2 and
HEX fractions did not produce an antidepressant-like effect when
administered at higher doses (10–100 mg/kg and 100 mg/kg,
respectively). This U-shaped dose–response curve, in predictive
tests of antidepressant activity, is commonly observed in the liter-
ature with plant extracts and their isolated compounds (Freitas
et al., 2010; Machado et al., 2008; Peng, Lo, Lee, Hung, & Lin,
2007). Such distinct biological effects may be due to differences
in the chemical compositions of fractions. Importantly, the exami-
nation of the fractions of this plant using HPLC revealed the pres-
ence of carnosol, betulinic acid and ursolic acid, as some of the
main compounds. The compounds that predominate in each frac-
tion can be decisive for the antidepressant potential of the frac-
tions. Therefore, carnosol is the major constituent of the AcOEt 1,
HEX and EOF fractions; whereas ursolic acid is the major com-
pound in the AcOEt 2 and ETOH fractions. It should be noted that
other compounds were also detected in these fractions, such as
betulinic acid, found mainly in the AcOEt 2, ETOH and EOF frac-
tions, rosmarinic acid in the EOF fraction and oleanolic acid in
the AcOEt 2 fraction.
The antidepressant-like effect of the acutely administered car-
nosol (0.01–0.1 mg/kg, p.o.) and betulinic acid (10 mg/kg, p.o.)
was observed at low doses in the TST. However, despite the present
study indicating that carnosol and betulinic acid may be responsi-
ble for the antidepressant action of the fractions from R. ofﬁcinalis,
we cannot rule out the contribution of other phytochemical com-
pounds in this biological effect. It is noteworthy that ursolic acid,
isolated from R. ofﬁcinalis, was also effective in producing an anti-
depressant-like effect in the TST in mice and this action may be due
to involvement of the dopaminergic system (Machado et al.,
unpublished data). Furthermore, rosmarinic and caffeic acids were
shown to produce an antidepressant effect in the FST (Takeda, Tsu-
ji, Inazu, Egashira, & Matsumiya, 2002).
The present study showed that the essential oil of R. ofﬁcinalis
also produced an antidepressant-like effect (0.1–100 mg/kg, p.o.)
in TST, without altering the locomotion in the open-ﬁeld test.
Interestingly, our results are in agreement with a recent study that
reported that the essential oil of R. ofﬁcinalis produced an antide-
pressant-like effect in the FST, another predictive test of antide-
pressant activity, in rats (Seol et al., 2010). The chemical analysis
revealed that the essential oil of this plant contained, as main com-
pounds: 1,8-cyneol (45.1%), camphor (21.8%), borneol (4.77%), a-
pinene (4.62%), and a-terpineol (4.57%). In general, the essential
oil of R. ofﬁcinalis can be classiﬁed into three chemotypes, based
on a chemical analysis of its predominant compounds, namely,
cineoliferum (high content in 1,8-cineole), camphoriferum (camphor
>20%) and verbenoniferum (verbenone >15%). Importantly, the
chemical analysis is complex and many other chemotypes have
been recognised according to the relative abundance of relevant
compounds, such as a-pinene and other constituents (Napoli, Cur-
curuto, & Ruberto, 2010). Moreover, the diversity of chemotypes
can be explained by the fact that this plant is cultivated in different
regions, with a variety of soil conditions and climate, that interfere
with the phytochemical composition of the essential oil, as well as
chemotypes. In the present study, considering the high content of
1,8-cineole (45.1%) in the essential oil, it may be characterised as
the cineoliferum chemoype. It remains to be established if 1,8-cin-
eole is the compound responsible for the antidepressant-like effect
of the essential oil from R. ofﬁcinalis.5. Conclusion
This study suggests that the antidepressant potential of several
fractions of R. ofﬁcinalis L may be attributed, at least in part, to the
presence of carnosol and betulinic acid. Moreover, the essential oilof this plant also produced an antidepressant-like effect and its
main compound, 1,8-cineole, may be involved in this action. How-
ever, other compounds could play a role in the antidepressant-like
effect of R. ofﬁcinalis L. and further studies are in progress in order
to clarify the bioactive principles responsible for these activities, as
well as the mechanisms underlying their action. The present study
clearly reinforces the notion that R. ofﬁcinalis has a therapeutic po-
tential as an antidepressant, since the effects of all fractions, iso-
lated compounds and essential oil in the TST are similar to that
produced by the classical antidepressant ﬂuoxetine. Considering
the widespread use of this plant as a condiment, its antidepressant
properties may be of pharmacological and nutraceutical interest
and should be conﬁrmed in future clinical studies.Acknowledgements
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